220 related articles for article (PubMed ID: 25774459)
1. Comparison of propofol pharmacokinetic and pharmacodynamic models for awake craniotomy: A prospective observational study.
Soehle M; Wolf CF; Priston MJ; Neuloh G; Bien CG; Hoeft A; Ellerkmann RK
Eur J Anaesthesiol; 2015 Aug; 32(8):527-34. PubMed ID: 25774459
[TBL] [Abstract][Full Text] [Related]
2. The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data.
Masui K; Upton RN; Doufas AG; Coetzee JF; Kazama T; Mortier EP; Struys MM
Anesth Analg; 2010 Aug; 111(2):368-79. PubMed ID: 19861357
[TBL] [Abstract][Full Text] [Related]
3. Propofol Pharmacodynamics and Bispectral Index During Key Moments of Awake Craniotomy.
Soehle M; Wolf CF; Priston MJ; Neuloh G; Bien CG; Hoeft A; Ellerkmann RK
J Neurosurg Anesthesiol; 2018 Jan; 30(1):32-38. PubMed ID: 27681862
[TBL] [Abstract][Full Text] [Related]
4. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
[TBL] [Abstract][Full Text] [Related]
5. Performance of TCI Propofol Using the Schnider Model for Cardiac Surgery on Cardiopulmonary Bypass-A Pilot Study.
Lee AKY; Kong AYH; Kong CF
J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):723-730. PubMed ID: 29225156
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the performance of the Marsh model in effect site mode for target controlled infusion of propofol during the maintenance phase of general anaesthesia in an unselected population of neurosurgical patients.
Cowley NJ; Hutton P; Clutton-Brock TH
Eur J Anaesthesiol; 2013 Oct; 30(10):627-32. PubMed ID: 23962821
[TBL] [Abstract][Full Text] [Related]
7. Predictive performance of the modified Marsh and Schnider models for propofol in underweight patients undergoing general anaesthesia using target-controlled infusion.
Lee YH; Choi GH; Jung KW; Choi BH; Bang JY; Lee EK; Choi BM; Noh GJ
Br J Anaesth; 2017 Jun; 118(6):883-891. PubMed ID: 28541533
[TBL] [Abstract][Full Text] [Related]
8. Effect site concentration during propofol TCI sedation: a comparison of sedation score with two pharmacokinetic models.
Barakat AR; Sutcliffe N; Schwab M
Anaesthesia; 2007 Jul; 62(7):661-6. PubMed ID: 17567340
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of bias in predicted and measured propofol concentrations during target-controlled infusions in obese Japanese patients: an open-label comparative study.
Tachibana N; Niiyama Y; Yamakage M
Eur J Anaesthesiol; 2014 Dec; 31(12):701-7. PubMed ID: 25192266
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic responses during induction: comparison of Marsh and Schnider pharmacokinetic models.
Yang XY; Zhou ZB; Yang L; Zhou X; Niu LJ; Feng X
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):32-40. PubMed ID: 25500489
[TBL] [Abstract][Full Text] [Related]
11. Predictive performance of a new pharmacokinetic model for propofol in underweight patients during target-controlled infusion.
Yi JM; Doh I; Lee SH; Kim SY; Lee YH; Lee EK; Lee SH; Choi BM; Noh GJ
Acta Anaesthesiol Scand; 2019 Apr; 63(4):448-454. PubMed ID: 30690713
[TBL] [Abstract][Full Text] [Related]
12. Study of the time course of the clinical effect of propofol compared with the time course of the predicted effect-site concentration: Performance of three pharmacokinetic-dynamic models.
Coppens M; Van Limmen JG; Schnider T; Wyler B; Bonte S; Dewaele F; Struys MM; Vereecke HE
Br J Anaesth; 2010 Apr; 104(4):452-8. PubMed ID: 20190259
[TBL] [Abstract][Full Text] [Related]
13. [Reevaluation of the time course of the effect of propofol described with the Schnider pharmacokinetic model].
Sepúlveda PO; Mora X
Rev Esp Anestesiol Reanim; 2012 Dec; 59(10):542-8. PubMed ID: 23040653
[TBL] [Abstract][Full Text] [Related]
14. External validation of the modified Marsh and Schnider models for medium-chain triglyceride propofol in target-controlled infusion anesthesia.
Lee S; Kang D; Song E; Yoo S; Jeong S
BMC Anesthesiol; 2024 Feb; 24(1):70. PubMed ID: 38395779
[TBL] [Abstract][Full Text] [Related]
15. Asleep-awake-asleep regimen for epilepsy surgery: a prospective study of target-controlled infusion versus manually controlled infusion technique.
Wang X; Wang T; Tian Z; Brogan D; Li J; Ma Y
J Clin Anesth; 2016 Aug; 32():92-100. PubMed ID: 27290954
[TBL] [Abstract][Full Text] [Related]
16. The asleep-awake technique using propofol-remifentanil anaesthesia for awake craniotomy for cerebral tumours.
Olsen KS
Eur J Anaesthesiol; 2008 Aug; 25(8):662-9. PubMed ID: 18289443
[TBL] [Abstract][Full Text] [Related]
17. Effect-Site Target-Controlled Infusion in the Obese: Model Derivation and Performance Assessment.
Cortínez LI; Sepúlveda P; Rolle A; Cottin P; Guerrini A; Anderson BJ
Anesth Analg; 2018 Oct; 127(4):865-872. PubMed ID: 29401079
[TBL] [Abstract][Full Text] [Related]
18. Propofol and remifentanil effect-site concentrations estimated by pharmacokinetic simulation and bispectral index monitoring during craniotomy with intraoperative awakening for brain tumor resection.
Lobo F; Beiras A
J Neurosurg Anesthesiol; 2007 Jul; 19(3):183-9. PubMed ID: 17592350
[TBL] [Abstract][Full Text] [Related]
19. Influence of Bayesian optimization on the performance of propofol target-controlled infusion.
van den Berg JP; Eleveld DJ; De Smet T; van den Heerik AVM; van Amsterdam K; Lichtenbelt BJ; Scheeren TWL; Absalom AR; Struys MMRF
Br J Anaesth; 2017 Nov; 119(5):918-927. PubMed ID: 29028925
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomised comparison of Marsh and Schnider pharmacokinetic models for propofol during induction of anaesthesia in elective cardiac surgery.
Viterbo JF; Lourenço AP; Leite-Moreira AF; Pinho P; Barros F
Eur J Anaesthesiol; 2012 Oct; 29(10):477-83. PubMed ID: 22935955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
